CM Management’s Cartesian Therapeutics RNAC Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-305,482	Closed	-$199K	–	69
2024 Q1	$199K	Sell	305,482 -394,518	-56%	-$256K	0.17%	68
2023 Q4	$483K	Hold	700,000	–	–	0.39%	57
2023 Q3	$742K	Hold	700,000	–	–	0.79%	42
2023 Q2	$784K	Buy	700,000 +100,000	+17%	+$112K	0.76%	41
2023 Q1	$834K	Hold	600,000	–	–	0.99%	39
2022 Q4	$678K	Hold	600,000	–	–	0.81%	42
2022 Q3	$984K	Hold	600,000	–	–	1.1%	33
2022 Q2	$786K	Buy	600,000 +100,000	+20%	+$131K	0.84%	40
2022 Q1	$615K	Buy	500,000 +100,000	+25%	+$123K	0.52%	57
2021 Q4	$1.3M	Hold	400,000	–	–	0.99%	32
2021 Q3	$1.66M	Hold	400,000	–	–	1.24%	28
2021 Q2	$1.67M	Hold	400,000	–	–	1.21%	29
2021 Q1	$1.81M	Buy	400,000 +75,000	+23%	+$339K	1.35%	20
2020 Q4	$985K	Buy	+325,000	New	+$985K	0.91%	37